Press Releases

Prospective, Multi-Institutional Study Shows Five Treatments with the CyberKnife® System Provide Excellent Disease Control for Prostate Cancer Patients SUNNYVALE, Calif., September 27, 2016 – Accuray Incorporated (NASDAQ: ARAY) announced today that data from a prospective, 21 center study showed 97 percent of low- and intermediate-risk prostate cancer patients had excellent cancer control five years after receiving stereotactic body radiation therapy (SBRT) administered with the CyberKnife® System. The treatment was extremely well-tolerated; serious side effects were uncommon (less than two percent) after more than five years of follow-up. The study was presented during an oral session yesterday at the American Society for Radiation Oncology (ASTRO) 58th Annual Meeting and was one of 15 to be selected out of thousands of abstracts for presentation during an ASTRO press conference, scheduled for today. Read More »
Accuray to Unveil New Technology at the ASTRO 2016 Annual Meeting SUNNYVALE, Calif., September 22, 2016 – New data on the Accuray (NASDAQ: ARAY) CyberKnife® and TomoTherapy® Systems will be shared by leading radiation oncology practitioners, and the Company’s new, innovative radiation therapy treatment delivery system, the Radixact™ System, and treatment planning software, will be unveiled at the 2016 ASTRO (American Society for Radiation Oncology) Annual Meeting in Boston, Massachusetts, September 25 – 28, 2016. ASTRO is the world's most important meeting for the radiation oncology community with more than 11,000 attendees each year. Meeting attendees are invited to attend the U.S. unveiling of the Radixact System at Accuray booth #2009 on Sunday, September 25 at 11:15 am ET. Read More »
Accuray to Participate in the Morgan Stanley Global Healthcare Conference 2016 SUNNYVALE, Calif., September 6, 2016-- Accuray Incorporated (NASDAQ: ARAY), announced today that Joshua H. Levine, President and Chief Executive Officer, is scheduled to present at the Morgan Stanley Global Healthcare Conference in New York on Wednesday, September 14, 2016 at 8:45 a.m. ET. Read More »
Accuray Reports Fourth Quarter and Fiscal 2016 Financial Results SUNNYVALE, Calif., August 17, 2016 – Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the fourth quarter and fiscal year ended June 30, 2016. Read More »
Accuray CE Marks its New Radixact™ System SUNNYVALE, Calif., August 9, 2016 – Accuray Incorporated (NASDAQ: ARAY) announced today that it has CE marked its Radixact™ Treatment Delivery System, Accuray Precision™ Treatment Planning System and iDMS™ Data Management System. The next generation hardware and software solutions, together, make up the new Radixact platform, which represents a major step forward in the evolution of Accuray’s existing TomoTherapy® System in treatment speed and ease of use. The platform will now be available in certain markets in the European Union (EU), in addition to the U.S. market where it received FDA 510(k) clearance in June 2016. Read More »
New Data Demonstrating TomoTherapy® System Adaptive Capabilities and Workhorse Reliability Presented at Leading Scientific Meeting for Medical Physicists SUNNYVALE, Calif., August 4, 2016 – Accuray Incorporated (NASDAQ: ARAY) announced today that new studies demonstrating the TomoTherapy® System’s leading-edge adaptive therapy capabilities and value as a mainstream radiation therapy device were presented at the 58th Annual Meeting of the American Association of Physicists in Medicine (AAPM) held in Washington, DC, July 31 – August 4, 2016. More than 35 studies evaluating the system were shared during poster and oral presentations. The TomoTherapy System is used worldwide to treat a wide range of cancer cases, from the routine to complex, with extreme precision. Read More »
New Data Show InCise™ Multileaf Collimator for the CyberKnife® M6™ System may Expand Patient Population Eligible for Precise Radiation Treatments SUNNYVALE, Calif., August 4, 2016 – Accuray Incorporated (NASDAQ: ARAY) announced today that more than 45 studies on the use of the CyberKnife® System were presented during poster and oral sessions at the 58th Annual Meeting of the American Association of Physicists in Medicine (AAPM) held in Washington, DC, July 31 – August 4, 2016. The CyberKnife System is the only stereotactic body radiation therapy (SBRT) system capable of tracking and automatically correcting for target motion in real time, even while the tumor moves. The System's sub-millimeter accuracy enables clinicians to effectively treat tumors while preserving healthy tissue. Read More »
Accuray Retires Remaining 3.75% Convertible Debt SUNNYVALE, Calif., August 2, 2016 – Accuray Incorporated (NASDAQ: ARAY) announced today the Company has settled the remaining principal amount and accrued interest thereon of the 3.75% Convertible Senior Notes (the “2016 Notes”). The 2016 Notes were settled on August 1, 2016 for cash of $37.3 million, which included $36.6 million in principal and $0.7 million in accrued interest. Read More »

Pages